InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Ruth Matthew R., Directeur Commercial. Officer active across 1 company, notably Opiant Pharmaceuticals, INC.. Aggregated, 6 filings have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €41k. History available since 19 July 2021. The latest transaction was filed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Ruth Matthew R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
19,250 股@ US$20.0083.7% 占其流量Common StockSEC:0001385508-23-000073:0
1,084 股@ US$10.622.6% 占其流量Common StockSEC:0001385508-22-000114:0
2,000 股0Common StockSEC:0001385508-22-000099:0
12,000 股0Common StockSEC:0001385508-22-000009:0
2,000 股@ US$17.347.3% 占其流量Common StockSEC:0001385508-21-000121:0
标准退出：2021年11月29日 (T+90)
15,000 股0Common StockSEC:0001385508-21-000096:0
6 条申报中的 6 条
About Ruth Matthew R.
Matthew R. Ruth is the Chief Commercial Officer at OPIANT PHARMACEUTICALS, INC. In this role, he is responsible for the company's commercial strategy and business development. His expertise in the pharmaceutical sector is essential to support OPIANT's growth. Matthew R. Ruth collaborates with his team to develop initiatives that promote product innovation and expansion.
